STOCK TITAN

Late Form 20-F puts Mynd.ai (NYSE: MYND) at NYSE listing risk

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
6-K

Rhea-AI Filing Summary

Mynd.ai, Inc. reported that it received a notice from NYSE American on May 18, 2026 stating it is not in compliance with continued listing requirements because it failed to timely file its Annual Report on Form 20-F for the year ended December 31, 2025 with the SEC.

The Form 20-F was due on May 15, 2026. Mynd.ai has an initial six-month cure period from that due date to file the report and regain compliance, with a possible additional six-month cure period at the exchange’s discretion. Its American Depositary Shares continue to trade on NYSE American while it works with advisors and auditors to complete the filing, but there is no assurance it will ultimately meet all listing standards.

Positive

  • None.

Negative

  • NYSE American non-compliance notice for late Form 20-F: Mynd.ai failed to file its Annual Report on Form 20-F for the year ended December 31, 2025 by the May 15, 2026 deadline, triggering a continued listing deficiency and potential future suspension or delisting if compliance is not restored within the cure periods.

Insights

Late Form 20-F filing triggers NYSE American listing deficiency risk.

Mynd.ai has missed the May 15, 2026 deadline for its Form 20-F, prompting a NYSE American notice under Section 1007. The company now faces a defined cure timeline to restore compliance through completion of its audited annual report.

The notice grants an initial six-month cure period from the due date, with a potential additional six months at the exchange’s discretion. Suspension or delisting procedures become possible if the filing is not completed within these windows, though ADS trading continues while the company remains otherwise compliant.

Management attributes the delay to accounting judgments and required disclosures for the year ended December 31, 2025, and states it is working with advisors and auditors. The company expresses an intention to file within the initial cure period but explicitly notes there is no assurance of ultimately meeting all NYSE American listing standards.

Form 20-F fiscal year end December 31, 2025 Year covered by the delayed Annual Report on Form 20-F
Form 20-F due date May 15, 2026 SEC filing deadline that was missed
Initial cure period length Six months Time from May 15, 2026 to file Form 20-F and regain compliance
Additional cure period length Up to six months Discretionary extra period NYSE American may grant after initial cure
Notice date May 18, 2026 Date NYSE American Regulation issued the non-compliance notice
Press release date May 22, 2026 Date of company press release about the NYSE American notice
continued listing requirements regulatory
"indicating that the Company is not in compliance with NYSE American LLC's continued listing requirements"
Rules a stock exchange sets that a publicly traded company must keep meeting to stay listed and tradable on that exchange, such as minimum share price, market value, timely financial reports, and basic governance practices. Like a club’s membership rules, they matter because falling short can lead to warnings, penalties or removal from the exchange, which can cut liquidity, hurt share value and increase the risk for investors.
Annual Report on Form 20-F regulatory
"its failure to timely file its Annual Report on Form 20-F for the year ended December 31, 2025"
An annual report on Form 20-F is a standardized filing that foreign companies submit to the U.S. securities regulator to disclose their financial results, business operations, risks, and management’s discussion of performance. It matters to investors because it provides a complete, audited snapshot—like a company’s financial report card and shareholder letter combined—used to assess transparency, compare companies, and judge whether the stock’s price matches underlying business strengths and risks.
Section 1007 of the NYSE American Company Guide regulatory
"The Notice was issued under Section 1007 of the NYSE American Company Guide, which governs late filings with the SEC."
Initial Cure Period regulatory
"the Company has a six-month period from the filing due date of May 15, 2026 (the “Initial Cure Period”) to file the Form 20-F"
A specified window of time given to a party under a contract to fix a problem or comply with an obligation before the other side can take stronger steps like stopping performance, seeking damages, or terminating the agreement. For investors it matters because the length and conditions of that grace period affect how quickly disputes can escalate, the likelihood of contract continuity, and potential financial or operational disruptions—think of it as a formal grace period to repair a leak before deciding whether to replace the roof.
Additional Cure Period regulatory
"may, in its sole discretion, grant an additional period of up to six months (the “Additional Cure Period”)"
An additional cure period is extra time written into a contract that lets a party fix a breach or missed payment before the other side can take harsh steps like ending the deal or calling a loan due. For investors, it matters because it can delay or prevent immediate losses, affect the timing of recoveries, and signal how quickly negative events might hit a company’s cash flow or share value—like a grace period to repair a leaky pipe before eviction.
forward-looking statements regulatory
"This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933"
Forward-looking statements are predictions or plans that companies share about what they expect to happen in the future, like estimating sales or profits. They matter because they help investors understand a company's outlook, but since they are based on guesses and assumptions, they can sometimes be wrong.

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16 UNDER
THE SECURITIES EXCHANGE ACT OF 1934

For the month of May 2026
Commission file number: 001-38203
Mynd.ai, Inc.
(Exact name of Registrant as specified in its charter)
Not applicable
(Translation of Registrant’s name into English)

Maples Corporate Services Limited,
PO Box 309,
Ugland House,
Grand Cayman KY1-1104
Cayman Islands
(Address of principal executive offices)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F ☒ Yes Form 40-F ☐ No




Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
On May 18, 2026, Mynd.ai, Inc. (“Mynd” or the “Company”) (NYSE American: MYND) received a notice (the "Notice") from the New York Stock Exchange Regulation (the “NYSE”) indicating that the Company is not in compliance with NYSE American LLC's ("NYSE American") continued listing requirements due to its failure to timely file its Annual Report on Form 20-F for the year ended December 31, 2025 (the "Form 20-F") with the U.S. Securities and Exchange Commission (the “SEC”). The Company has a six-month cure period to file the Form 20-F and regain compliance.
On May 22, 2026, the Company issued a press release announcing receipt of the delinquency notice. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.
Forward-Looking Statements
Certain statements made in this Form 6-K are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. The words “plan,” “will,” “believe,” “anticipate,” “doubt,” “expect,” “intend,” and similar terms and phrases are used in this press release to identify forward-looking statements, including statements regarding the Company’s ability to file its Form 20-F. Actual results may differ materially from the results anticipated by the Company’s forward-looking statements due to certain risks, uncertainties and other factors described under the heading “Risk Factors” in the Company’s filings with the Securities and Exchange Commission. Given these risks, uncertainties, and other factors, you should not place undue reliance on these forward-looking statements, and the Company assumes no obligation to update these forward-looking statements, even if new information becomes available in the future.
EXHIBIT INDEX
Exhibit No
Description
99.1
Press Release dated May 22, 2026




SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.            
                                
Mynd.ai, Inc.
By:
/s/ Arthur Giterman
Name:
Arthur Giterman
Date: May 22, 2026
Title:
Chief Executive Officer & Chief Financial Officer


Exhibit 99.1
Mynd.ai Receives Notice from NYSE American Regarding Late Filing of Annual Report on Form 20-F

Alpharetta, G.A., May 22, 2026 – Mynd.ai, Inc. (“Mynd” or the “Company”) (NYSE American: MYND) today announced that on May 18, 2026, the Company received a notice (the "Notice") from the New York Stock Exchange Regulation (the “NYSE”) indicating that the Company is not in compliance with NYSE American LLC's ("NYSE American") continued listing requirements due to its failure to timely file its Annual Report on Form 20-F for the year ended December 31, 2025 (the "Form 20-F") with the U.S. Securities and Exchange Commission (the “SEC”).
The Notice was issued under Section 1007 of the NYSE American Company Guide, which governs late filings with the SEC. Under this rule, the Company has a six-month period from the filing due date of May 15, 2026 (the “Initial Cure Period”) to file the Form 20-F and regain compliance. If the Company does not regain compliance within the Initial Cure Period, the NYSE American may, in its sole discretion, grant an additional period of up to six months (the “Additional Cure Period”), or may determine to commence suspension and delisting procedures.
As disclosed in the Form 12b-25 filed by the Company on April 30, 2026, the Company was unable, without unreasonable effort or expense, to file the Form 20-F as a result of delays in reaching conclusions on certain accounting judgments and disclosures required to be included in its financial statements for the fiscal year ending December 31, 2025. The Company is working diligently with its advisors and auditors to complete the Form 20-F and intends to file within the Initial Cure Period. However, there can be no assurance that the Company will ultimately regain compliance with all applicable NYSE American listing standards.
The Notice has no immediate impact on the listing of the Company’s American Depositary Shares, which will continue to trade on the NYSE American, subject to the Company’s compliance with other continued listing requirements.
About Mynd.ai, Inc.
Alpharetta-based Mynd is a global leader in interactive technology offering best-in-class hardware and software solutions that help organizations create and deliver dynamic content; simplify and streamline teaching, learning, and communication; and facilitate real-time collaboration. Our award-winning interactive displays and software can be found in more than 1 million learning and training spaces in over 125 countries. Our global distribution network of more than 1,000 reseller partners and our dedicated sales and support teams around the world enable us to deliver the highest level of service to our customers.
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. The words “plan,” “will,” “believe,” “anticipate,” “doubt,” “expect,” “intend,” and similar terms and phrases are used in this press release to identify forward-looking statements, including statements regarding the Company’s ability to file its Form 20-F. Actual results may differ materially from the results anticipated by the Company’s forward-looking statements due to certain risks, uncertainties and other factors described under the heading “Risk Factors” in the Company’s filings with the Securities and Exchange Commission. Given these risks, uncertainties, and other factors, you should not place undue reliance on these forward-looking statements, and the Company assumes no obligation to update these forward-looking statements, even if new information becomes available in the future.
1




For investor and media inquiries, please contact:
Investor Relations - Mynd.ai, Inc.
E-mail: investorrelations@mynd.ai
Chief Financial Officer
officeoftheCFO@mynd.ai
Tel: (206) 393-4443
2


FAQ

Why did Mynd.ai (MYND) receive a NYSE American non-compliance notice?

Mynd.ai received the notice because it failed to timely file its Annual Report on Form 20-F for the year ended December 31, 2025 by the May 15, 2026 SEC deadline, violating NYSE American continued listing requirements.

How long does Mynd.ai have to cure its late Form 20-F filing?

Mynd.ai has an initial six-month cure period from the May 15, 2026 Form 20-F due date to regain compliance by filing. NYSE American may, at its discretion, grant an additional cure period of up to six more months.

What happens if Mynd.ai does not file its Form 20-F within the cure period?

If Mynd.ai does not file its Form 20-F within the initial six-month cure period, NYSE American may grant an additional six months or may begin suspension and delisting procedures, depending on the exchange’s discretionary assessment.

Are Mynd.ai’s American Depositary Shares still trading on NYSE American?

Yes. The company states that the NYSE American notice has no immediate impact on the listing of its American Depositary Shares, which continue to trade on NYSE American, subject to compliance with other continued listing requirements.

Why was Mynd.ai unable to file its Form 20-F on time?

Mynd.ai previously disclosed in a Form 12b-25 that it could not file the Form 20-F without unreasonable effort or expense due to delays in reaching conclusions on certain accounting judgments and disclosures for the 2025 financial statements.

Does Mynd.ai guarantee it will regain NYSE American compliance?

No. While Mynd.ai states it is working diligently with advisors and auditors and intends to file the Form 20-F within the initial cure period, it cautions there can be no assurance it will ultimately meet all applicable NYSE American listing standards.

Filing Exhibits & Attachments

1 document